| 3.6 |
10.7 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 3.0 |
9.1 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 2.3 |
6.8 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 2.0 |
9.9 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 1.7 |
5.2 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 1.5 |
1.5 |
GO:0072050 |
comma-shaped body morphogenesis(GO:0072049) S-shaped body morphogenesis(GO:0072050) |
| 1.4 |
5.6 |
GO:0055099 |
regulation of Cdc42 protein signal transduction(GO:0032489) response to high density lipoprotein particle(GO:0055099) platelet dense granule organization(GO:0060155) |
| 1.3 |
14.8 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 1.3 |
3.9 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 1.3 |
6.4 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 1.3 |
3.8 |
GO:0033087 |
negative regulation of immature T cell proliferation(GO:0033087) |
| 1.2 |
3.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 1.1 |
1.1 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 1.1 |
2.2 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 1.0 |
5.1 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 1.0 |
3.0 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 1.0 |
3.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 1.0 |
4.9 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 1.0 |
2.9 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.9 |
0.9 |
GO:0045581 |
negative regulation of T cell differentiation(GO:0045581) |
| 0.9 |
2.7 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.9 |
2.7 |
GO:0030421 |
defecation(GO:0030421) |
| 0.9 |
6.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.8 |
9.3 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.8 |
7.6 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.8 |
8.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.8 |
4.1 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.7 |
26.7 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.7 |
6.6 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.7 |
11.0 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.7 |
2.7 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.7 |
7.5 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.7 |
5.4 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
| 0.7 |
4.6 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.7 |
2.6 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.7 |
2.6 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.6 |
1.9 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.6 |
3.8 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.6 |
3.8 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.6 |
2.5 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.6 |
18.4 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.6 |
1.9 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.6 |
1.8 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.6 |
2.9 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.6 |
2.3 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.6 |
1.1 |
GO:0032817 |
regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
| 0.5 |
1.5 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.5 |
3.4 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.5 |
1.4 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.5 |
1.4 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.5 |
1.8 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.5 |
5.9 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 |
3.1 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.4 |
1.8 |
GO:0034239 |
regulation of macrophage fusion(GO:0034239) |
| 0.4 |
0.9 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.4 |
2.2 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.4 |
1.3 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.4 |
2.2 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.4 |
2.1 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.4 |
2.1 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.4 |
2.1 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.4 |
3.0 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.4 |
1.3 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.4 |
1.7 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.4 |
1.7 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.4 |
1.2 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.4 |
4.4 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.4 |
1.2 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.4 |
1.6 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.4 |
4.9 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.4 |
9.1 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.4 |
1.5 |
GO:0003344 |
pericardium morphogenesis(GO:0003344) |
| 0.4 |
3.7 |
GO:1902287 |
semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.4 |
1.5 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.4 |
4.2 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.4 |
0.4 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.3 |
1.0 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.3 |
4.4 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.3 |
1.7 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.3 |
3.3 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.3 |
1.3 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.3 |
3.9 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.3 |
1.3 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.3 |
2.5 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.3 |
4.3 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 0.3 |
2.2 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.3 |
2.1 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.3 |
0.9 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.3 |
0.9 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.3 |
4.2 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.3 |
1.8 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.3 |
1.2 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.3 |
1.5 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.3 |
0.9 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.3 |
0.8 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 0.3 |
4.1 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.3 |
1.1 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.3 |
1.1 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.3 |
4.1 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.3 |
2.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 |
1.1 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.3 |
2.1 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.3 |
1.0 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.3 |
0.8 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.3 |
2.0 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.3 |
0.8 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.3 |
0.8 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.3 |
2.0 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.2 |
2.0 |
GO:0002674 |
negative regulation of acute inflammatory response(GO:0002674) |
| 0.2 |
0.7 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 |
1.7 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 |
0.5 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.2 |
1.5 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.2 |
0.9 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.2 |
0.9 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 |
1.2 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 0.2 |
2.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
3.2 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.2 |
3.4 |
GO:1900746 |
regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.2 |
0.2 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 |
1.0 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.2 |
1.2 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.2 |
2.7 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
2.1 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
0.6 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.2 |
0.8 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.2 |
1.6 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.2 |
1.0 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.2 |
0.4 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.2 |
1.4 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
1.6 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.2 |
1.9 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
0.6 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 |
0.6 |
GO:0097709 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
| 0.2 |
1.5 |
GO:0030183 |
B cell differentiation(GO:0030183) |
| 0.2 |
1.3 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
0.7 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.2 |
0.9 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 |
2.1 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.2 |
0.5 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.2 |
0.9 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.2 |
0.7 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
1.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 |
0.8 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 0.2 |
2.7 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.2 |
4.3 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
0.3 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.2 |
0.5 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 |
0.6 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 |
0.8 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.2 |
0.9 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.7 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
3.5 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.3 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.1 |
2.0 |
GO:0042297 |
auditory behavior(GO:0031223) vocal learning(GO:0042297) imitative learning(GO:0098596) observational learning(GO:0098597) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.1 |
1.9 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 |
0.6 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
0.6 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.1 |
3.6 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
0.7 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 0.1 |
0.7 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
0.4 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.1 |
2.2 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.8 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
0.7 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 |
0.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.6 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.9 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
2.9 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
0.6 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.1 |
0.1 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.1 |
0.4 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) |
| 0.1 |
1.8 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
1.0 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
3.7 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
4.2 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 |
0.5 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.1 |
1.3 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.7 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.4 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.5 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 |
0.4 |
GO:2001180 |
negative regulation of interleukin-18 production(GO:0032701) negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.1 |
0.6 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.1 |
0.3 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.1 |
0.2 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.1 |
1.0 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
1.2 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.2 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.1 |
2.4 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.1 |
1.8 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.4 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.7 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
1.8 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.1 |
0.5 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
2.4 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
1.9 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
3.8 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.1 |
3.2 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
1.3 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
2.2 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.1 |
2.2 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
20.5 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.1 |
0.5 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 |
5.7 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.3 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.1 |
0.7 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
4.0 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.1 |
0.5 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
0.9 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.1 |
0.9 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
0.6 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.5 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.3 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
0.5 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 |
1.1 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.1 |
1.8 |
GO:0009952 |
anterior/posterior pattern specification(GO:0009952) |
| 0.1 |
0.3 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.1 |
0.5 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.6 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.1 |
1.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
1.1 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
| 0.1 |
0.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.5 |
GO:0051095 |
regulation of helicase activity(GO:0051095) |
| 0.1 |
0.1 |
GO:0033700 |
phospholipid efflux(GO:0033700) |
| 0.1 |
0.9 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.1 |
1.5 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
0.3 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
2.2 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.1 |
0.3 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.1 |
0.5 |
GO:0016075 |
rRNA catabolic process(GO:0016075) RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
1.2 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.1 |
0.2 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 |
0.3 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
1.4 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.1 |
0.5 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.5 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
2.2 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
1.9 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.2 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.9 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 0.1 |
0.1 |
GO:0014042 |
positive regulation of neuron maturation(GO:0014042) |
| 0.1 |
1.1 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 |
0.1 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 |
0.5 |
GO:0032196 |
transposition(GO:0032196) |
| 0.1 |
1.7 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 |
1.4 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.1 |
1.4 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
0.5 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.1 |
0.3 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.1 |
0.7 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
1.6 |
GO:0060349 |
bone morphogenesis(GO:0060349) |
| 0.1 |
0.3 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.4 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
1.8 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 0.1 |
0.1 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.1 |
0.6 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
1.1 |
GO:0010453 |
regulation of cell fate commitment(GO:0010453) |
| 0.1 |
0.5 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.1 |
0.6 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.8 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.4 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 |
0.6 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.1 |
0.4 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.2 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.6 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 |
0.4 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.1 |
0.4 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
1.7 |
GO:0045143 |
homologous chromosome segregation(GO:0045143) |
| 0.1 |
0.1 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.1 |
0.4 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 |
0.4 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
0.5 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.8 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.7 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.2 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.1 |
2.5 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.1 |
0.4 |
GO:1902592 |
multi-organism membrane organization(GO:0044803) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 |
1.2 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
1.3 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.4 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
1.1 |
GO:0097553 |
release of sequestered calcium ion into cytosol(GO:0051209) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
| 0.0 |
0.1 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.0 |
0.8 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.3 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.4 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.3 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.3 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
2.6 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.0 |
1.8 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.0 |
0.9 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
1.2 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
1.4 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.2 |
GO:0035826 |
hypotonic response(GO:0006971) rubidium ion transport(GO:0035826) cellular hypotonic response(GO:0071476) |
| 0.0 |
0.4 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.0 |
0.4 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
1.0 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.5 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.0 |
1.2 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.4 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.1 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 |
0.4 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.0 |
0.2 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.8 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.1 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.0 |
0.6 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.4 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.5 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.5 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.3 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
1.3 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.3 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.0 |
0.3 |
GO:0061117 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
| 0.0 |
0.3 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.0 |
0.5 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.5 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
1.1 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.5 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.2 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 |
0.1 |
GO:2001179 |
interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 |
0.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
1.0 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.4 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 |
0.7 |
GO:0071222 |
cellular response to biotic stimulus(GO:0071216) cellular response to molecule of bacterial origin(GO:0071219) cellular response to lipopolysaccharide(GO:0071222) |
| 0.0 |
0.1 |
GO:1902524 |
interferon-alpha biosynthetic process(GO:0045349) interferon-beta biosynthetic process(GO:0045350) regulation of interferon-alpha biosynthetic process(GO:0045354) regulation of interferon-beta biosynthetic process(GO:0045357) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.0 |
0.3 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.4 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
1.2 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
0.1 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.0 |
0.3 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.9 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.0 |
0.1 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.0 |
0.9 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.3 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 |
0.4 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.0 |
0.2 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.0 |
1.3 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 0.0 |
0.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.1 |
GO:1900364 |
negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
0.2 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.0 |
0.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.1 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.7 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.1 |
GO:0051447 |
negative regulation of meiotic cell cycle(GO:0051447) |
| 0.0 |
1.2 |
GO:0007631 |
feeding behavior(GO:0007631) |
| 0.0 |
0.2 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.8 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.1 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.0 |
0.2 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.3 |
GO:0002209 |
behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
| 0.0 |
0.1 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.0 |
0.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.4 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) |
| 0.0 |
0.7 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.5 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
1.4 |
GO:0030178 |
negative regulation of Wnt signaling pathway(GO:0030178) |
| 0.0 |
0.2 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.7 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.2 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.3 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.7 |
GO:0021549 |
cerebellum development(GO:0021549) |
| 0.0 |
0.9 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
1.4 |
GO:0040008 |
regulation of growth(GO:0040008) |
